TRIS PHARMA, INC

ATTENCIAL

Pharmaceutical preparations, including modified release and/or extended release compositions containing as an active pharmaceutical ingredient at least an amphetamine and/or amphetamines;

BENZONEX

Pharmaceutical preparations for the treatment of sore throats, coughs, colds, allergies and respiratory diseases, and symptoms of the same;

CODTXR

Pharmaceutical, dietary, and medical preparations in solid dosage form, namely, drug delivery systems comprising a drug-ion exchange resin complex for long acting or modified release or sustained release or controlled release action of the active in the drug-ion exchange resin complex;Scientific research services for the development of preparations or products in solid form that delivers contents in a short or prolonged action or sustained release or controlled release over time up to 24 hours after swallowing for pharmaceuticals, nutraceuticals or for use in human or animal species;

DYANAVEL

Pharmaceutical preparations which act on the central nervous system, including modified release and/or extended release compositions containing as an active pharmaceutical ingredient at least an amphetamine and/or amphetamines;

KARBINAL

Oral extended release pharmaceutical preparations for the drug carbinoxamine, intended for the treatment of seasonal and perennial allergic rhinitis;

KARBINAL

Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses;

MYKIDZ

vitamins, nutritional supplements, and dietary supplements; medicinal preparations for treating nasal congestion and pain for infants and pediatric use; nutritional iron supplements; docosahexaenoic acid (DHA) nutritional supplements; Omega-3 nutritional supplements; medicated diaper rash ointments, creams and lotions; preparations for use in the treatment of nasal congestion; lice treatment preparations; nasal spray preparations; dietetic foods adapted for medical purposes that help in the treatment of diarrhea; dietetic foods adapted for medical purposes that help improve cognitive function; probiotic supplements;MY KIDS;

NEXICLON

Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism;

TRIS

Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain;Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations;

TRIS PHARMA

Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet, cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain;TRIS PHARMACEUTICAL;Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations;PHARMA;